View Financial HealthACI Formulations 배당 및 자사주 매입배당 기준 점검 2/6ACI Formulations 수익으로 충분히 충당되는 현재 수익률 1.81% 보유한 배당금 지급 회사입니다.핵심 정보1.8%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률-3.7%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향33%최근 배당 및 자사주 매입 업데이트공시 • Oct 30ACI Formulations PLC announces Annual dividend, payable on January 27, 2026ACI Formulations PLC announced Annual dividend of BDT 2.5000 per share payable on January 27, 2026, ex-date on November 20, 2025 and record date on November 19, 2025.Upcoming Dividend • Nov 14Upcoming dividend of ৳2.00 per shareEligible shareholders must have bought the stock before 18 November 2024. Payment date: 28 January 2025. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Bangladeshi dividend payers (4.5%). Lower than average of industry peers (7.4%).Declared Dividend • Oct 31Dividend of ৳2.00 announcedShareholders will receive a dividend of ৳2.00. Ex-date: 18th November 2024 Payment date: 28th January 2025 Dividend yield will be 1.7%, which is lower than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (42% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Upcoming Dividend • Nov 12Upcoming dividend of ৳2.50 per share at 1.6% yieldEligible shareholders must have bought the stock before 19 November 2023. Payment date: 28 January 2024. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Bangladeshi dividend payers (3.3%). Lower than average of industry peers (2.2%).공시 • Oct 28ACI Formulations Limited Recommends Cash Dividend for the Year Ended June 30, 2022ACI Formulations Limited has recommended 25% cash dividend for the year ended June 30, 2022.Upcoming Dividend • Nov 14Upcoming dividend of ৳3.00 per shareEligible shareholders must have bought the stock before 21 November 2021. Payment date: 25 January 2022. Trailing yield: 1.9%. Lower than top quartile of Bangladeshi dividend payers (3.0%). In line with average of industry peers (2.0%).모든 업데이트 보기Recent updatesBoard Change • 11hLess than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Nasreen Sattar was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 22ACI Formulations PLC to Report Q3, 2026 Results on Apr 29, 2026ACI Formulations PLC announced that they will report Q3, 2026 results on Apr 29, 2026공시 • Jan 21ACI Formulations PLC to Report Q2, 2026 Results on Jan 29, 2026ACI Formulations PLC announced that they will report Q2, 2026 results on Jan 29, 2026공시 • Nov 10ACI Formulations PLC to Report Q1, 2026 Results on Nov 12, 2025ACI Formulations PLC announced that they will report Q1, 2026 results on Nov 12, 2025공시 • Oct 30ACI Formulations PLC announces Annual dividend, payable on January 27, 2026ACI Formulations PLC announced Annual dividend of BDT 2.5000 per share payable on January 27, 2026, ex-date on November 20, 2025 and record date on November 19, 2025.공시 • Oct 29ACI Formulations PLC, Annual General Meeting, Dec 28, 2025ACI Formulations PLC, Annual General Meeting, Dec 28, 2025, at 10:00 Central Asia Standard Time.공시 • Oct 21ACI Formulations PLC to Report Fiscal Year 2025 Results on Oct 28, 2025ACI Formulations PLC announced that they will report fiscal year 2025 results on Oct 28, 2025공시 • Apr 21ACI Formulations Limited to Report Q3, 2025 Results on Apr 29, 2025ACI Formulations Limited announced that they will report Q3, 2025 results on Apr 29, 2025공시 • Jan 22ACI Formulations Limited to Report Q2, 2025 Results on Jan 30, 2025ACI Formulations Limited announced that they will report Q2, 2025 results on Jan 30, 2025New Risk • Nov 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (93% net debt to equity). Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (৳5.68b market cap, or US$47.3m).Upcoming Dividend • Nov 14Upcoming dividend of ৳2.00 per shareEligible shareholders must have bought the stock before 18 November 2024. Payment date: 28 January 2025. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Bangladeshi dividend payers (4.5%). Lower than average of industry peers (7.4%).공시 • Nov 11ACI Formulations Limited to Report Q1, 2025 Results on Nov 14, 2024ACI Formulations Limited announced that they will report Q1, 2025 results on Nov 14, 2024Declared Dividend • Oct 31Dividend of ৳2.00 announcedShareholders will receive a dividend of ৳2.00. Ex-date: 18th November 2024 Payment date: 28th January 2025 Dividend yield will be 1.7%, which is lower than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (42% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.공시 • Oct 21ACI Formulations Limited to Report Fiscal Year 2024 Results on Oct 28, 2024ACI Formulations Limited announced that they will report fiscal year 2024 results on Oct 28, 2024Reported Earnings • May 02Third quarter 2024 earnings released: EPS: ৳2.04 (vs ৳1.33 in 3Q 2023)Third quarter 2024 results: EPS: ৳2.04 (up from ৳1.33 in 3Q 2023). Revenue: ৳1.23b (down 5.7% from 3Q 2023). Net income: ৳96.4m (up 54% from 3Q 2023). Profit margin: 7.8% (up from 4.8% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 6% per year.공시 • Apr 26ACI Formulations Limited to Report Q3, 2024 Results on Apr 29, 2024ACI Formulations Limited announced that they will report Q3, 2024 results on Apr 29, 2024Reported Earnings • Feb 18Second quarter 2024 earnings released: EPS: ৳2.70 (vs ৳2.49 in 2Q 2023)Second quarter 2024 results: EPS: ৳2.70 (up from ৳2.49 in 2Q 2023). Revenue: ৳1.39b (down 3.3% from 2Q 2023). Net income: ৳127.6m (up 8.6% from 2Q 2023). Profit margin: 9.2% (up from 8.2% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year.공시 • Jan 23ACI Formulations Limited to Report Q2, 2024 Results on Jan 30, 2024ACI Formulations Limited announced that they will report Q2, 2024 results on Jan 30, 2024Upcoming Dividend • Nov 12Upcoming dividend of ৳2.50 per share at 1.6% yieldEligible shareholders must have bought the stock before 19 November 2023. Payment date: 28 January 2024. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Bangladeshi dividend payers (3.3%). Lower than average of industry peers (2.2%).공시 • Oct 31+ 1 more updateACI Formulations Limited, Annual General Meeting, Dec 28, 2023ACI Formulations Limited, Annual General Meeting, Dec 28, 2023, at 10:00 Bangladesh Standard Time.공시 • Oct 20ACI Formulations Limited to Report Fiscal Year 2023 Results on Oct 26, 2023ACI Formulations Limited announced that they will report fiscal year 2023 results on Oct 26, 2023공시 • Jun 12ACI Formulations Limited Announces Executive ChangesACI Formulations Limited has informed that the Board of Directors approved the resignation of the previous company secretary, Mr. Nayamul Hoque. The Board also decided that Mr. Mohammad Mostafizur Rahman will be the acting Company Secretary of the company until the new Company Secretary is appointed to this position.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Golam Mainuddin was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Oct 28ACI Formulations Limited Recommends Cash Dividend for the Year Ended June 30, 2022ACI Formulations Limited has recommended 25% cash dividend for the year ended June 30, 2022.Reported Earnings • May 28Third quarter 2022 earnings released: EPS: ৳1.53 (vs ৳1.48 in 3Q 2021)Third quarter 2022 results: EPS: ৳1.53 (up from ৳1.48 in 3Q 2021). Revenue: ৳1.16b (up 5.0% from 3Q 2021). Net income: ৳72.1m (up 2.8% from 3Q 2021). Profit margin: 6.2% (down from 6.4% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ৳161, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total returns to shareholders of 27% over the past three years.Valuation Update With 7 Day Price Move • May 10Investor sentiment improved over the past weekAfter last week's 23% share price gain to ৳205, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 32x in the Chemicals industry in Bangladesh. Total returns to shareholders of 55% over the past three years.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Golam Mainuddin was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 06Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: ৳2.59 (up from ৳1.96 in 2Q 2021). Revenue: ৳1.27b (up 19% from 2Q 2021). Net income: ৳122.5m (up 32% from 2Q 2021). Profit margin: 9.6% (in line with 2Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improved over the past weekAfter last week's 15% share price gain to ৳179, the stock trades at a trailing P/E ratio of 34.2x. Average trailing P/E is 34x in the Chemicals industry in Bangladesh. Total returns to shareholders of 24% over the past three years.Upcoming Dividend • Nov 14Upcoming dividend of ৳3.00 per shareEligible shareholders must have bought the stock before 21 November 2021. Payment date: 25 January 2022. Trailing yield: 1.9%. Lower than top quartile of Bangladeshi dividend payers (3.0%). In line with average of industry peers (2.0%).Valuation Update With 7 Day Price Move • Sep 12Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳190, the stock trades at a trailing P/E ratio of 44.5x. Average trailing P/E is 40x in the Chemicals industry in Bangladesh. Total returns to shareholders of 27% over the past three years.Is New 90 Day High Low • Feb 23New 90-day low: ৳113The company is down 5.0% from its price of ৳119 on 25 November 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 11New 90-day high: ৳126The company is up 9.0% from its price of ৳116 on 13 October 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 6.0% over the same period.Is New 90 Day High Low • Nov 02New 90-day low: ৳111The company is down 12% from its price of ৳127 on 04 August 2020. The Bangladeshi market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: ACIFORMULA 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: ACIFORMULA 의 배당금 지급액은 지난 10 년 동안 감소했습니다.배당 수익률 vs 시장ACI Formulations 배당 수익률 vs 시장ACIFORMULA의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (ACIFORMULA)1.8%시장 하위 25% (BD)0.8%시장 상위 25% (BD)4.0%업계 평균 (Chemicals)9.7%분석가 예측 (ACIFORMULA) (최대 3년)n/a주목할만한 배당금: ACIFORMULA 의 배당금( 1.81% )은 BD 시장에서 배당금 지급자의 하위 25%( 0.81% )보다 높습니다.고배당: ACIFORMULA 의 배당금( 1.81% )은 BD 시장에서 배당금 지급자의 상위 25%( 3.96% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 33.5% )로 ACIFORMULA 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: ACIFORMULA 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YBD 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 04:32종가2026/05/20 00:00수익2026/03/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스ACI Formulations PLC는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Oct 30ACI Formulations PLC announces Annual dividend, payable on January 27, 2026ACI Formulations PLC announced Annual dividend of BDT 2.5000 per share payable on January 27, 2026, ex-date on November 20, 2025 and record date on November 19, 2025.
Upcoming Dividend • Nov 14Upcoming dividend of ৳2.00 per shareEligible shareholders must have bought the stock before 18 November 2024. Payment date: 28 January 2025. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Bangladeshi dividend payers (4.5%). Lower than average of industry peers (7.4%).
Declared Dividend • Oct 31Dividend of ৳2.00 announcedShareholders will receive a dividend of ৳2.00. Ex-date: 18th November 2024 Payment date: 28th January 2025 Dividend yield will be 1.7%, which is lower than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (42% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Upcoming Dividend • Nov 12Upcoming dividend of ৳2.50 per share at 1.6% yieldEligible shareholders must have bought the stock before 19 November 2023. Payment date: 28 January 2024. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Bangladeshi dividend payers (3.3%). Lower than average of industry peers (2.2%).
공시 • Oct 28ACI Formulations Limited Recommends Cash Dividend for the Year Ended June 30, 2022ACI Formulations Limited has recommended 25% cash dividend for the year ended June 30, 2022.
Upcoming Dividend • Nov 14Upcoming dividend of ৳3.00 per shareEligible shareholders must have bought the stock before 21 November 2021. Payment date: 25 January 2022. Trailing yield: 1.9%. Lower than top quartile of Bangladeshi dividend payers (3.0%). In line with average of industry peers (2.0%).
Board Change • 11hLess than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Nasreen Sattar was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 22ACI Formulations PLC to Report Q3, 2026 Results on Apr 29, 2026ACI Formulations PLC announced that they will report Q3, 2026 results on Apr 29, 2026
공시 • Jan 21ACI Formulations PLC to Report Q2, 2026 Results on Jan 29, 2026ACI Formulations PLC announced that they will report Q2, 2026 results on Jan 29, 2026
공시 • Nov 10ACI Formulations PLC to Report Q1, 2026 Results on Nov 12, 2025ACI Formulations PLC announced that they will report Q1, 2026 results on Nov 12, 2025
공시 • Oct 30ACI Formulations PLC announces Annual dividend, payable on January 27, 2026ACI Formulations PLC announced Annual dividend of BDT 2.5000 per share payable on January 27, 2026, ex-date on November 20, 2025 and record date on November 19, 2025.
공시 • Oct 29ACI Formulations PLC, Annual General Meeting, Dec 28, 2025ACI Formulations PLC, Annual General Meeting, Dec 28, 2025, at 10:00 Central Asia Standard Time.
공시 • Oct 21ACI Formulations PLC to Report Fiscal Year 2025 Results on Oct 28, 2025ACI Formulations PLC announced that they will report fiscal year 2025 results on Oct 28, 2025
공시 • Apr 21ACI Formulations Limited to Report Q3, 2025 Results on Apr 29, 2025ACI Formulations Limited announced that they will report Q3, 2025 results on Apr 29, 2025
공시 • Jan 22ACI Formulations Limited to Report Q2, 2025 Results on Jan 30, 2025ACI Formulations Limited announced that they will report Q2, 2025 results on Jan 30, 2025
New Risk • Nov 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (93% net debt to equity). Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (৳5.68b market cap, or US$47.3m).
Upcoming Dividend • Nov 14Upcoming dividend of ৳2.00 per shareEligible shareholders must have bought the stock before 18 November 2024. Payment date: 28 January 2025. Payout ratio is a comfortable 42% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Bangladeshi dividend payers (4.5%). Lower than average of industry peers (7.4%).
공시 • Nov 11ACI Formulations Limited to Report Q1, 2025 Results on Nov 14, 2024ACI Formulations Limited announced that they will report Q1, 2025 results on Nov 14, 2024
Declared Dividend • Oct 31Dividend of ৳2.00 announcedShareholders will receive a dividend of ৳2.00. Ex-date: 18th November 2024 Payment date: 28th January 2025 Dividend yield will be 1.7%, which is lower than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (42% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
공시 • Oct 21ACI Formulations Limited to Report Fiscal Year 2024 Results on Oct 28, 2024ACI Formulations Limited announced that they will report fiscal year 2024 results on Oct 28, 2024
Reported Earnings • May 02Third quarter 2024 earnings released: EPS: ৳2.04 (vs ৳1.33 in 3Q 2023)Third quarter 2024 results: EPS: ৳2.04 (up from ৳1.33 in 3Q 2023). Revenue: ৳1.23b (down 5.7% from 3Q 2023). Net income: ৳96.4m (up 54% from 3Q 2023). Profit margin: 7.8% (up from 4.8% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 6% per year.
공시 • Apr 26ACI Formulations Limited to Report Q3, 2024 Results on Apr 29, 2024ACI Formulations Limited announced that they will report Q3, 2024 results on Apr 29, 2024
Reported Earnings • Feb 18Second quarter 2024 earnings released: EPS: ৳2.70 (vs ৳2.49 in 2Q 2023)Second quarter 2024 results: EPS: ৳2.70 (up from ৳2.49 in 2Q 2023). Revenue: ৳1.39b (down 3.3% from 2Q 2023). Net income: ৳127.6m (up 8.6% from 2Q 2023). Profit margin: 9.2% (up from 8.2% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 9% per year.
공시 • Jan 23ACI Formulations Limited to Report Q2, 2024 Results on Jan 30, 2024ACI Formulations Limited announced that they will report Q2, 2024 results on Jan 30, 2024
Upcoming Dividend • Nov 12Upcoming dividend of ৳2.50 per share at 1.6% yieldEligible shareholders must have bought the stock before 19 November 2023. Payment date: 28 January 2024. Payout ratio is a comfortable 47% but the company is not cash flow positive. Trailing yield: 1.6%. Lower than top quartile of Bangladeshi dividend payers (3.3%). Lower than average of industry peers (2.2%).
공시 • Oct 31+ 1 more updateACI Formulations Limited, Annual General Meeting, Dec 28, 2023ACI Formulations Limited, Annual General Meeting, Dec 28, 2023, at 10:00 Bangladesh Standard Time.
공시 • Oct 20ACI Formulations Limited to Report Fiscal Year 2023 Results on Oct 26, 2023ACI Formulations Limited announced that they will report fiscal year 2023 results on Oct 26, 2023
공시 • Jun 12ACI Formulations Limited Announces Executive ChangesACI Formulations Limited has informed that the Board of Directors approved the resignation of the previous company secretary, Mr. Nayamul Hoque. The Board also decided that Mr. Mohammad Mostafizur Rahman will be the acting Company Secretary of the company until the new Company Secretary is appointed to this position.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Golam Mainuddin was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Oct 28ACI Formulations Limited Recommends Cash Dividend for the Year Ended June 30, 2022ACI Formulations Limited has recommended 25% cash dividend for the year ended June 30, 2022.
Reported Earnings • May 28Third quarter 2022 earnings released: EPS: ৳1.53 (vs ৳1.48 in 3Q 2021)Third quarter 2022 results: EPS: ৳1.53 (up from ৳1.48 in 3Q 2021). Revenue: ৳1.16b (up 5.0% from 3Q 2021). Net income: ৳72.1m (up 2.8% from 3Q 2021). Profit margin: 6.2% (down from 6.4% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ৳161, the stock trades at a trailing P/E ratio of 27.5x. Average trailing P/E is 28x in the Chemicals industry in Bangladesh. Total returns to shareholders of 27% over the past three years.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improved over the past weekAfter last week's 23% share price gain to ৳205, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 32x in the Chemicals industry in Bangladesh. Total returns to shareholders of 55% over the past three years.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Golam Mainuddin was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 06Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: EPS: ৳2.59 (up from ৳1.96 in 2Q 2021). Revenue: ৳1.27b (up 19% from 2Q 2021). Net income: ৳122.5m (up 32% from 2Q 2021). Profit margin: 9.6% (in line with 2Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment improved over the past weekAfter last week's 15% share price gain to ৳179, the stock trades at a trailing P/E ratio of 34.2x. Average trailing P/E is 34x in the Chemicals industry in Bangladesh. Total returns to shareholders of 24% over the past three years.
Upcoming Dividend • Nov 14Upcoming dividend of ৳3.00 per shareEligible shareholders must have bought the stock before 21 November 2021. Payment date: 25 January 2022. Trailing yield: 1.9%. Lower than top quartile of Bangladeshi dividend payers (3.0%). In line with average of industry peers (2.0%).
Valuation Update With 7 Day Price Move • Sep 12Investor sentiment improved over the past weekAfter last week's 17% share price gain to ৳190, the stock trades at a trailing P/E ratio of 44.5x. Average trailing P/E is 40x in the Chemicals industry in Bangladesh. Total returns to shareholders of 27% over the past three years.
Is New 90 Day High Low • Feb 23New 90-day low: ৳113The company is down 5.0% from its price of ৳119 on 25 November 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 11New 90-day high: ৳126The company is up 9.0% from its price of ৳116 on 13 October 2020. The Bangladeshi market is up 15% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 6.0% over the same period.
Is New 90 Day High Low • Nov 02New 90-day low: ৳111The company is down 12% from its price of ৳127 on 04 August 2020. The Bangladeshi market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is flat over the same period.